GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Valuation Rank

Akanda (Akanda) Valuation Rank


View and export this data going back to 2022. Start your Free Trial

What is Akanda Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Akanda Valuation Rank Related Terms

Thank you for viewing the detailed overview of Akanda's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Akanda (Akanda) Business Description

Traded in Other Exchanges
Address
1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU
Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.